Epidemiological and Clinical Characteristics of 217 COVID-19 Patients in Northwest Ohio, United States.
clinical findings
covid-19
epidemiological findings
northwest ohio
predictors of mortality
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
05 Apr 2021
05 Apr 2021
Historique:
entrez:
3
6
2021
pubmed:
4
6
2021
medline:
4
6
2021
Statut:
epublish
Résumé
Background There is limited data on the clinical characteristics and predictors of mortality of coronavirus disease-2019 (COVID-19) in North West Ohio. We performed a retrospective review of patients hospitalized with COVID-19 in the ProMedica Health System in Northwest Ohio from March 25 to June 16, 2020. The study aims to identify epidemiological, clinical characteristics, and predictors of Mortality of COVID-19 patients in Northwest Ohio. Methods This study was conducted on 217 COVID-19 patients admitted to ProMedica Health System Hospitals in Northwest Ohio from March 25 to June 16, 2020. We collected data, including clinical signs, symptoms, and outcomes of the COVID-19 patients. We compared clinical signs and symptoms along with comorbidities of survivors and non-survivors. Results Of the 217 patients included in the study, the mean age of the population was 63.13 (SD 17.8), of which 194 (89.4%, mean age 61.7 years) survived while 23 (10.6%, mean age 74.6 years) died. Among them, 53% were females and 47% male. Common presenting symptoms were chest pain (91.71%), shortness of breath (79.7%), cough (71%), and fever (64%). Mortality was associated with age greater than 63 (p-value 0.0052) and hypertension (p-value: 0.0058) with marginal significance with gender (p-value: 0.0642), chest pain (p-value: 0.0944), and history of cancer (p-value: 0.0944). Conclusions Advanced age and hypertension (HTN) are independent predictors for increased mortality. History of cancer and chest pain are associated with increased mortality with marginal significance. Awareness among physicians about predictors of mortality is essential in dealing with COVID-19 patients. It is essential to educate the public about preventative strategies such as wearing masks to decrease mortality and morbidity from this pandemic.
Identifiants
pubmed: 34079643
doi: 10.7759/cureus.14308
pmc: PMC8162051
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e14308Informations de copyright
Copyright © 2021, Balla et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Diagnosis (Berl). 2020 May 26;7(2):91-96
pubmed: 32352401
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
Clin Med (Lond). 2020 Mar;20(2):124-127
pubmed: 32139372
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574
pubmed: 32397011
BMJ Open Diabetes Res Care. 2020 Apr;8(1):
pubmed: 32345579
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
J Clin Med Res. 2020 Apr;12(4):215-229
pubmed: 32362969
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244365
Clin Microbiol Infect. 2020 Jul;26(7):948.e1-948.e3
pubmed: 32360780
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
Int J Epidemiol. 2020 Aug 1;49(4):1085-1095
pubmed: 32588051
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
World J Clin Cases. 2020 Jun 26;8(12):2554-2565
pubmed: 32607332
Cureus. 2020 Nov 28;12(11):e11752
pubmed: 33403182
Cureus. 2020 Jun 30;12(6):e8918
pubmed: 32760619
JAMA. 2020 May 26;323(20):2089-2090
pubmed: 32320008
J Clin Med Res. 2020 May;12(5):315-319
pubmed: 32489507
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32269086
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950
pubmed: 32301284
J Clin Med Res. 2020 Jun;12(6):352-361
pubmed: 32587651
JAMA. 2020 Jun 23;323(24):2512-2514
pubmed: 32432682
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
Cureus. 2021 Feb 1;13(2):e13052
pubmed: 33643747